#United States #New York #Class Action #Gross Law Firm #Hims & Hers

Important Notice for Hims & Hers Health, Inc. Investors

On July 17, 2025, The Gross Law Firm released a critical announcement for shareholders of Hims & Hers Health, Inc. (NYSE: HIMS), inviting those who invested during a specified period to engage with the firm regarding a pending class action lawsuit. This lawsuit comes in response to allegations concerning misleading statements made by the company, which raises significant implications for affected investors.

Overview of the Class Action Lawsuit

The class action applies to shareholders who purchased shares of Hims from April 29, 2025, to June 23, 2025. The allegations claim that during this period, Hims & Hers engaged in misleading business practices, including the dubious promotion and sale of illegitimate versions of Wegovy®, an FDA-approved medication. Such actions purportedly jeopardized patient safety, potentially jeopardizing Hims' collaboration with the reputable pharmaceutical company, Novo Nordisk.

The lawsuit alleges that the company's executives made statements about Hims’ business operations and future prospects that turned out to be materially misleading. As a result, shareholders may have suffered financial loss based on these deceptive practices. It is crucial for investors affected by these actions to understand their rights and the next steps they should take.

Importance of Registering as a Plaintiff

Shareholders are encouraged to register by August 25, 2025, if they wish to be informed about the progress of the lawsuit and may also seek the role of lead plaintiff, although such a designation is not mandatory to participate in any financial recovery. Registering allows investors to be enrolled in monitoring software, ensuring they receive consistent updates throughout the lawsuit process.

For affected shareholders, this is a significant opportunity to advocate for their rights while seeking potential compensation for any financial damages incurred as a result of Hims' alleged deceptive practices.

Next Steps for Shareholders

To participate in the lawsuit, shareholders should visit the dedicated link provided by The Gross Law Firm and submit their information. This will ensure they receive all necessary updates about the case and their rights as involved parties. They're reminded that engaging in this action comes at no cost or obligation to them, which further emphasizes the safety of their investment in this legal procedure.

Why Choose The Gross Law Firm?

The Gross Law Firm has built a reputation as a nationally recognized class action law firm, known for its commitment to protecting investors against fraud and deceitful business practices. Their goal is to ensure that companies uphold their responsibilities and conduct business ethically and legally. The firm understands the importance of restoring investor trust and holding corporations accountable when they fail to provide transparent and truthful information about their operations.

For shareholders who experienced losses due to what they believe to be misleading statements made by Hims & Hers, contacting the Gross Law Firm is a proactive step. They can provide both representation and support in navigating this complex situation.

Contact Information

For more information or to register for the class action, interested parties should reach out to The Gross Law Firm directly:

• - Address: 15 West 38th Street, 12th Floor, New York, NY 10018
• - Email: [email protected]
• - Phone: (646) 453-8903

Investors affected by these claims should not delay in asserting their rights and ensuring their representation in this pending class action lawsuit.

• ---

Disclaimer: This announcement from The Gross Law Firm does not guarantee similar outcomes but aims to inform and encourage affected shareholders about their legal options.